Skip to main content

Outbreak of measles in Central and Eastern Cheshire, UK, October 2008–February 2009

  • S. GHEBREHEWET (a1), G. HAYHURST (a2), A. KEENAN (a1) and H. MOORE (a3)

We describe the largest outbreak of measles in Central and Eastern Cheshire (North West England) since the MMR vaccine was introduced in 1988, the majority of cases were not vaccinated and more than 20% of the cases belonged to the travelling community. Over 4 months, 147 clinical cases of measles were notified locally to the Cheshire & Merseyside Health Protection Unit (CMHPU). Of these, 67 (45·6%) were laboratory confirmed, 42 (28·6%) were negative, and one was equivocal, leaving 23 probable and 14 possible cases. The primary case was probably an 8-year-old unvaccinated travelling child, symptomatic on 1 October 2008. Measles spread locally and within school-aged children until early February 2009. Most of Central and Eastern Cheshire, including 23 educational institutions (playgroups, nurseries, primary schools, secondary schools, colleges), were affected, showing that there were enough susceptible/unvaccinated children to sustain an outbreak. Nearly a quarter of the confirmed cases (15/67, 22·4%) were aged <13 months and too young to be vaccinated under the UK immunization schedule. This outbreak is a reminder of the importance of achieving herd immunity to prevent spread and protect those at risk of severe illness or complications. There were no fatalities in this outbreak and no significant complications were reported.

Corresponding author
*Author for correspondence: Dr S. Ghebrehewet, Cheshire & Merseyside Health Protection Unit, 5th Floor, Rail House, Lord Nelson Street, Liverpool L1 1JF, UK. (Email:
Hide All
1.Parliamentary Office of Science and Technology. Vaccines and public health. Postnote, 2004, No. 219 ( Accessed 21 November 2011.
2.Salisbury D, Ramsay M, Noakes K (eds). Immunisation against Infectious Disease Department of Health, 2011 (updated). ( Accessed 21 January 2011.
3.Chin J (ed.). Control of Communicable Disease Manual, 17th edn.Washington DC: American Public Health Association, 2000.
4.Katz M. Clinical spectrum of measles and MA. Current Topics in Microbiology and Immunology 1995; 191: 312.
5.Miller CL, et al. The epidemiology of subacute sclerosing encephalitis in England and Wales 1990–2002. Archives of Disease in Childhood 2004; 89: 11451148.
6.Miller CL. Farrington CP, Harbert K.The epidemiology of subacute sclerosing encephalitis in England and Wales 1970–1989. International Journal of Epidemiology 1992; 21: 9981006.
7.World Health Organisation (WHO). Measles fact sheet ( Accessed 21 November 2011.
8.Health Protection Agency. Confirmed measles cases in England and Wales – an update to end of May 2008 ( Accessed 14 August 2012.
9.Wakefield A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 1999; 351: 637641.
10.Editors of the Lancet. Retraction – Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [Editorial]. Lancet 2010; 375: 445.
11.Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001; 19: 36323635.
12.Taylor B, et al. Measles, mumps and rubella vaccination and bowel problems or developmental regression in children with autism: population study. British Medical Journal 2002; 324:393396.
13.Nicholson MS, Leask J. Lessons from an online debate about measles-mumps-rubella (MMR) immunisation. Vaccine 2012; 30: 38063812.
14.Muscat M, et al. Measles in Europe: an epidemiological assessment. Lancet 2009; 373: 383389.
15.Health Protection Agency. Confirmed measles cases in England and Wales – an update to end of May 2008. Health Protection Report, 2008; 2; 21 ( Accessed 25 November 2011.
16.Health Protection Agency. Confirmed measles cases in England and Wales – an update to end of May 2008. Health Protection Report, 2008; 2; 25 ( Accessed 2 August 2012.
17.NHS Immunisation Statistics England 2010–11. The NHS Information Services, 2011 ( Accessed 21 November 2011.
18.NHS Immunisation Statistics 2004–05. The NHS Information Services, 2005 ( Accessed 21/11/11).
19.Wilkins J, Wehrie PF. Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunisation [Abstract]. Journal of Paediatrics 1979; 94: 865869.
20.Albrecht P, et al. Persistence of maternal antibodies beyond 12 months: mechanism of measles vaccine failure [Abstract]. Journal of Paediatrics 1977; 91: 715718.
21.Leuridan E, et al. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. British Medical Journal 2010; 340: c1626.
22.Klinge J, et al. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine 2000; 18: 31343140.
23.Feder GS, Vaclavik T, Streetly A. Traveller gypsies and childhood immunisations: a study in east London. British Journal of General Practice 1993; 43: 281284.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 6
Total number of PDF views: 20 *
Loading metrics...

Abstract views

Total abstract views: 144 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.